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Abstract: Capsinoids exhibit health-promoting properties 
and are therefore compounds of interest for medical and 
food sciences. They are minor compounds present in 
relatively high concentrations in only a few number of 
pepper cultivars. It is desirable to quantify capsinoids to 
provide selected cultivars with high capsinoid contents, 
which can then be employed as health food product. 
Quantifying low concentrations of capsinoids from 
pepper fruit requires a precise and selective analytical 
technique such as HPLC coupled to electrospray ionization 
- mass spectrometry, with development of an internal 
standard essential. In this work, the synthesis method 
of a novel compound analogue of capsinoids, the (±)-3,4-
dimethoxybenzyl-4-methyloctanoate, which could be a 
suitable internal standard for capsinoid determination by 
electrospray ionization - mass spectrometry is described. 
(±)-3,4-dimethoxybenzyl-4-methyloctanoate was stable 
under the analysis conditions and exerted chemical and 
physical properties similar to those of capsinoids. This 
internal standard will provide an accurate capsinoid 
determination by electrospray ionization - mass 
spectrometry, thus facilitating the pepper breeding 
programs, screening pepper cultivars and a better 
understanding of capsinoid biosynthetic pathway.
Keywords: ???
Introduction 1  
Capsinoids are analogues to capsaicinoids, these are the 
main compounds responsible for pungency in pepper fruits 
(Capsicum spp.), and both are exclusively produced by fruits 
of this genus [1-7]. Although capsinoids also contribute to 
this effect, they are approximately 1,000 times less pungent 
than capsaicinoids [7]. Capsinoids are similar in structure 
to capsaicinoids, with the exception of an ester bond in 
the place of an amide bond found in capsaicinoids [8]. 
Until now, three capsinoids have been identified in nature: 
capsiate, dihydrocapsiate, and nordihydrocapsiate, with 
the first two the most common [8,9]. Both, capsaicinoids 
and capsinoids are powerful biocompounds with 
health-promoting properties, such as anti-oxidant, anti-
inflammatory, anti-obesity, and analgesic activities [10-
13]. They are also used in arthritis treatments, digestive 
disorders or in some diseases like cancer, among others 
[14-17]. The advantage of capsinoids over capsaicinoids 
is that these do not present side effects like irritancy or a 
burning feeling [18,19]. Therefore, capsinoids could have a 
greater application range both in medical field and in food 
sciences, in the development of new drugs for long-term 
treatments or functional foods. In this regard, identifying 
pepper cultivars with high capsinoid content becomes 
really attractive for human consumption, pharmaceutical 
purposes and pepper breeding programs.
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2    O Fayos et al.
The analytical techniques used, routinely in 
laboratories, for capsinoid determination are high 
performance liquid chromatography (HPLC) coupled to 
UV or PDA/DAD detectors [2-4,20]. Since capsinoids and 
capsaicinoids are measured at the same wavelength (280 
nm), their concentration could be overestimated by these 
techniques, which are based only on retention time and 
UV spectra, and could assign erroneously a peak to a 
given capsinoid. A promising high-resolution detection 
technique such as electrospray ionization (ESI)-mass 
spectrometry (MS) in combination with HPLC, would 
enable a more accurate, precise, and sensitive analysis of 
these compounds. This technique allows an unequivocal 
identification of compounds by exact mass-to-charge 
ratio (m/z), molecular formula and fragmentation pattern, 
all of them distinctive features for each compound [21-24]. 
Nevertheless, the addition of an internal standard (IS) to 
the sample is of crucial importance in order to improve 
the analytical parameters, avoid ionization fluctuations of 
analytes, and correct errors in detection [21-27]. Currently, 
there are not any commercially available internal standards 
for capsinoid analysis by HPLC-ESI-MS. Isotope-labeled 
analogues could be the internal standards. However, they 
have disadvantages, such as their scarce availability and 
high price. Thus, chemical synthesis is an interesting 
alternative to isotopic labelling for obtaining new synthetic 
analogues to capsinoids [22, 28]. 
In this report, we describe for first time a simple 
synthesis approach of the (±)-3,4-dimethoxybenzyl-4-
methyloctanoate ((±)-DMBO), a novel synthetic analogue 
to capsinoids, and their potential use as IS for capsiate and 
dihydrocapsiate determination by HPLC-ESI-MS(QTOF). 
Materials and methods2  
Chemicals and reagents2.1  
For (±)-DMBO synthesis: 3,4-dimethoxybenzaldehyde 
(99%) (1), and (±)-4-methyloctanoic acid (98%) (3), and 
di-isobutyl aluminium hydride (1 mol L-1 in toluene) 
(DIBAL) were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). Sodium sulphate anhydrous (99%), 
dehydrated pyridine (99%), and tetrahydrofuran (THF) 
(99.5%) were purchased from Panreac Química S.L.U. 
(Barcelona, Spain). Ethyl acetate, methanol, and hexane, 
all of them HPLC grade, were procured from Scharlab S.L. 
(Barcelona, Spain). Thionyl chloride (SOCl2) (99%) was 
purchased from Merck Schuchardt OHG (Hohenbrunn, 
Germany). Capsiate and dihydrocapsiate standards were 
supplied by the Department of Organic Chemistry at the 
University of Cádiz, Spain. All standard solutions were 
prepared with analytical grade type I water (Milli-Q 
Synthesis, Millipore, Bedford, MA). 
2.2 General experimental procedures2.2  
The synthesis of (±)-DMBO (5) was accomplished in three 
stages: reduction of the 3,4-dimethoxybenzaldehyde 
(1) carbonyl group, chloride formation from 
(±)-4-methyloctanoic acid (3) and esterification of 3,4-
dimethoxybenzyl alcohol (2) with (±)-4-methyloctanoyl 
chloride (4).
The (±)-DMBO purity was determined by 1H NMR and 
13C NMR analysis. 1H and 13C spectra were recorded using 
deuterated chloroform (CDCl3) (99.8%, Sigma-Aldrich 
Chemical Co. St. Louis, MO, USA) as the solvent, on an 
Agilent INOVA spectrometer (Agilent Technologies, Santa 
Clara, CA, USA) at 499.719 and 125.654 MHz, respectively. 
The resonances of residual chloroform for 1H and 13C were 
set to δH 7.25 ppm and δC 77.00 ppm, respectively, and used 
as internal reference. UV-Vis spectra were obtained by 
using a Varian Cary 50 BIO spectrophotometer (Agilent 
Technologies) with chloroform as the solvent. General 
IR spectra (KBr) were recorded on a Perkin-Elmer FT-IR 
Spectrum 2 spectrophotometer (PerkinElmer, Waltham, 
MA, USA). The reactions were monitored by thin-layer 
chromatography (TLC) on silica gel (F245 Merck plates).
HPLC-ESI-MS and ESI-MS/MS(QTOF) 2.3  
analysis
Individual standard solutions in 60% methanol (20 
µmol L-1 for (±)-DMBO and 10 µmol L-1 for capsiate and 
dihydrocapsiate) were introduced by direct injection with 
a syringe pump (Cole-Parmer Instrument Co., Vernon 
Hills, IL, USA) operating at 4 μL min-1, in a Quadrupole 
Time-of-Flight (QTOF) mass spectrometer equipped with 
an Electrospray Ionization Source (ESI) (MicrOTOF-Q, 
Bruker Daltonics, Bremen, Germany). ESI-MS(QTOF) and 
ESI-MS/MS(QTOF) analysis were carried out in positive-ion 
mode, with capillary and endplate offset voltages of 4500 
and -500 V, respectively, and using N2 as the collision gas. 
The collision cell energy was set to 10 eV, with an isolation 
width for the precursor ion of 2 mass-to-charge ratio (m/z) 
units. The nebulizer gas (N2) pressure, the drying gas (N2) 
flow rate and the drying gas temperature were 1.6 bar, 8.0 
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
 Synthesis of (±)-3,4-dimethoxybenzyl-4-methyloctanoate as a novel internal standard...   3
L min-1 and 200 ºC, respectively. Spectra were acquired in 
the m/z 50–800 range. The mass axis was calibrated by 
using Na-formate adducts [10 mmol L-1 NaOH, 2.5% (v/v) 
formic acid and 50% (v/v) 2-propanol] that were introduced 
through a divert valve at the beginning of each direct 
injection. For MS/MS spectra the [M+Na]+ ions with m/z 
values of 329 and 331 m/z for capsiate and dihydrocapsiate 
and (±)-DMBO, respectively, were chosen as precursors, 
with an isolation width of 4 m/z units and an amplitude 
voltage of 0.45 V. The structures of capsiate, (±)-DMBO, 
and dihydrocapsiate are shown in Table 1. Bruker Daltonik 
software packages micrOTOF Control v.2.3 and HyStar 
v.3.2 were used to control the system. Data Analysis 
v.4.0 was used to process data. Capsiate, (±)-DMBO, and 
dihydrocapsiate standards were detected by coupling 
the HPLC instrument to the QTOF mass spectrometer. 
Chromatographic separation was performed on an 
Agilent 1100 series HPLC system (Agilent Technologies, 
Waldbron, Germany) equipped with an isocratic pump, an 
autosampler, and a thermostated column compartment. 
The column used was an analytical HPLC C18 column 
(Symmetry C18, 2.1 x 150 mm; 3.5 μm spherical particle 
size, Waters, Milford, MA, USA) protected by a guard 
column (Symmetry C18, 2.1 mm i.d. x 10 mm length, 3.5 
μm spherical particle size, Waters). The HPLC conditions 
were methanol (solvent A) and Milli-Q water acidified with 
0.1% (v/v) acetic acid (solvent B) as eluents, 0.2 µL min-1 
as flow rate, 25 ºC as column temperature, and 5 μL as 
injection volume. The elution program was set according 
to the following gradient: 0-7 min, 60% B; 7-15 min, 60-
70% B; 15-52 min, 70-100% B.
Ethical approval: The conducted research is not 
related to either human or animals use.
Results and discussion3  
(±)-DMBO Synthesis procedure (5) 3.1  
Reduction of the 3,4-dimethoxybenzaldehyde (1) 3.1.1  
carbonyl group
The initial reaction stage involved the reduction of the 
carbonyl group of 3,4-dimethoxybenzaldehyde (1) to its 
corresponding alcohol (2) (Figure 1). The reduction of the 
carbonyl group was performed by using DIBAL (1 mol L-1 
in toluene). The compound (1) (3.0042 g, 0.0181 mol) was 
dissolved in 40 mL of dry THF. Subsequently, 2 equivalents 
of DIBAL (1 mol L-1 in toluene) were added slowly, with a 
syringe, in an ice bath, and the reaction mixture was 
stirred, under argon, at ambient temperature, for 2 h. The 
reaction was monitored by TLC (eluent: 20% ethyl acetate, 
80% hexane; chromogenic reagent: anisaldehyde). Then, 
the reaction was stopped with water and after purification 
of the reaction mixture, by column chromatography 
(eluent: 20% ethyl acetate, 80% hexane; chromogenic 
reagent: anisaldehyde), and (2) was obtained with a yield 
of 77.16%. 
Table 1: Common name, chemical formula, molecular weight, and [M+Na]+ of capsiate, (±)-DMBO, and dihydrocapsiate.
Common Name Chemical Structure Chemical Formula Molecular Weight Measured [M+Na]+
Capsiate
 
Common Name Chemical Structure 
Chemical 
Formula 
Molecular 
Weight 
Measured 
[M+Na]+ 
Capsiate 
 
C18H26O4 306.3966 329.1678 
Dihydrocapsiate 
 
C18H28O4  308.4125 331.1879 
()-DMBO 
  
C18H28O4 308.4125 331.1855 
 
C18H26O4 306.3966 329.1678
Dihydrocapsiate
 
o on a e he ical Structure 
he ical 
For ula 
olecular 
eight 
easured 
[ + a]+ 
apsiate 
 
18 26 4 306.3966 329.1678 
ihydrocapsiate 
 
18 28 4  308.4125 331.1879 
()-  
  
18 28 4 308.4125 331.1855 
 
C18H28O4 308.4125 331.1879
(±)-DMBO
O
H3CO
O
H3CO
 
C18H28O4 308.4125 331.1855
Figure 1: Step 1 of the synthesis procedure of (±)-DMBO. Reduction of 
3,4-dimethoxybenzaldehyde (1) to 3,4-dimethoxybenzyl alcohol (2).
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Chloride formation from (±)-4-methyloctanoic acid 3.1.2  
(3) 
The (±)-4-methyloctanoic acid (3) was transformed into 
(±)-4-methyloctanoyl chloride (4), in order to subsequently 
perform the acylation of this compound (2) (Figure 2). 
To do so, 2 equivalents of (3) (4.4307 g, 0.028 mol) were 
placed in a 50-mL round-bottom flask into which argon 
was introduced. An amount of SOCl2, sufficient to dissolve 
the acid, was added very slowly, dropwise from a syringe, 
and stirred magnetically. After the addition of SOCl2, the 
reaction mixture was heated at 60ºC for 1 h. Subsequently, 
the excess of SOCl2 excess was eliminated in vacuo, and 
the transparent oil of (4) was obtained. This compound 
(4) was dissolved in dry THF for the subsequent acylation 
with compound (2). 
Esterification of 3,4-dimethoxybenzyl alcohol (2) 3.1.3  
with (±)-4-methyloctanoyl chloride (4)
The (±)-3,4-dimethoxybenzyl-4-methyloctanoate 
((±)-DMBO) (5) was prepared by the acylation of 
the 3,4-dimethoxybenzyl alcohol ring (2) using a 
(±)-4-methyloctanoyl chloride chain (4) (Figure 3). The 
final product (±)-DMBO (5) is a racemic mixture since 
the synthesis has been started from the racemic product 
(±)-4-methylocatanoic acid (3) and the proposed synthesis 
is not stereoselective. Compound (2) (2.3321 g, 0.0140 
mol) was dissolved in 20-25 mL of dry pyridine (py) in a 
50-mL round-bottom flask under a protective atmosphere 
with argon. Then, 2 equivalents of (4) were added slowly 
to this solution and agitated for 18 h. The reaction was 
monitored by TLC (eluent: 20% ethyl acetate, 80% hexane; 
chromogenic reagent: anisaldehyde) up to the reaction´s 
completion.
The (±)-DMBO esterification step was simpler than 
that reported for capsinoid and capsaicinoids standards 
synthesis [29]. Through this synthesis procedure, (±)-DMBO 
(5) was obtained, after purification of the reaction mixture, 
with a yield of 95% and a purity ≥ 98%. The overall yield 
obtained for the synthesis of (±)-DBMO starting from the 
initial material has therefore been 73.15%. This yield was 
higher than those obtained by other synthesis procedures 
previously reported for capsinoid and capsaicinoid 
standards [12,29-33]. Thus, this procedure would be an 
efficient alternative to other synthesis methodologies 
for capsinoid derivatives, such as enzymatic catalysis or 
labeled compound synthesis, due to its lower cost and 
higher yield. 
Chemical characterization of (±)-DMBO 3.2  
(5)
The formation of (±)-DMBO was confirmed by 1H NMR 
and 13C NMR analysis. Since (±)-DMBO (5) (Figure 4) has 
never been previously described in the bibliography, its 
chemical characterization is presented below:
Yellow oil. 1H NMR (500 MHz, CDCl3, δ, ppm) 
(Assignments with identical superscripts are 
interchangeable) (S1 _Figure): 6.91 (dd, 1H, J = 2.0 Hz, J = 
8.1 Hz, 6), 6.87 (bd, 1H, J = 1.9 Hz, 2), 6.83 (bd, 1H, J = 8.1 
Hz, 5), 5.03 (s, 2H, 8), 3.87 (sa, 3H, 7), 3.86 (sa, 3H, 7´), 2.38-
2.26 (m, 2H, 2”), 1.69-1.63 (m, 1H, 3a”), 1.47-1.41 (m, 1H, 3b”), 
1.41-1.35 (m, 1H, 4”), 1.30-1.17 (m, 1H, 5a”), 1.30-1.17 (m, 2H, 
7”), 1.30-1.17 (m, 2H, 6”), 1.12-1.07 (m, 1H, 5b”), 0.86 (t, 3H, J 
= 6.4 Hz, 8”), 0.84 (d, 3H, J = 6.5 Hz, 9”); 13C NMR (125 MHz, 
CDCl3, δ, ppm): 173.98 (1”), 148.99b (4), 148.91b (3), 128.59 
(1), 121.17 (6), 111.70 (2), 110.94 (5), 66.14 (8), 55.85c (7), 
55.81c (7´), 36.27 (5”), 32.31 (4”), 32.12 (2”), 31.85 (3”), 29.09 
(6”), 22.87 (7”), 19.24 (9”), 14.05 (8”); IR (cm–1): 2956, 1735, 
Figure 2: Step 2 of the synthesis procedure of (±)-DMBO. 
Preparation of (±)-4-methyloctanoyl chloride (4) from 
(±)-4-methyloctanoic acid (3).
Figure 3: Step 3 of the synthesis procedure of (±)-DMBO. Procedure for the preparation of (±)-DMBO (5) from the acylation of 3,4-
dimethoxybenzyl alcohol (2) with (±)-4-methyloctanoyl chloride (4).
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1519, 1162; λmax (nm) 279.9; ε (L/mol·cm-1) 338; HRMS (ESI) 
calculated for C18H28O4 [M+Na]+: 331.1879, found: 331.1884. 
HPLC-ESI-MS(QTOF) and HPLC-ESI-MS/3.3  
MS(QTOF) analysis of capsiate, (±)-DMBO, 
and dihydrocapsiate standards
In order to evaluate the suitability of (±)-DMBO as an IS 
for capsinoid determination by ESI-mass spectrometry, its 
retention time and ionization behaviour were determined 
by HPLC-ESI-MS(QTOF) and HPLC-ESI-MS/MS(QTOF) 
and compared to those of capsiate and dihydrocapsiate 
standards.
The MS spectra of capsiate, (±)-DMBO, and 
dihydrocapsiate were acquired, in positive ion mode, by 
direct injection of the standard solutions on the QTOF 
mass analyser. The major peaks observed in the MS 
spectra corresponding with the [M+Na]+ ions were at the 
m/z 329.1678 for capsiate, 331.1879 for dihydrocapsiate 
and 331.1855 for (±)-DMBO (Table 1). These molecular ions 
were in agreement with the calculated m/z 329.1723 for 
capsiate and 331.1880 for (±)-DMBO and dihydrocapsiate; 
therefore, they were selected as precursors for ESI-MS/
MS experiments. Figure 5 shows the MS/MS spectra 
obtained for capsiate, (±)-DMBO, and dihydrocapsiate. 
For both capsinoid standards, the most intense peak 
was observed at m/z 159.0375 for capsiate and 159.0418 
for dihydrocapsiate, in accordance with the calculated 
m/z 159.0417, corresponding to sodiated vanillyl ring. 
Other minor product ions detected at m/z 137.0570 and 
137.0605, in conformity with the calculated m/z 137.0597, 
corresponding to the protonated vanillyl ring of capsiate 
and dihydrocapsiate, respectively, and generated by 
the cleavage of the C7-O8 bond of these molecules 
(Figure 5, A and B). On (±)-DMBO MS/MS spectrum, 
the most intense peak was observed at m/z 151.0750 
(Figure 5C), in agreement with the calculated m/z 
151.0754 for the expected vanillyl-type ring resulting from 
fragmentation at the ester bond. The ionization behaviour 
and break site of (±)-DMBO molecules were similar to those 
Figure 4: Chemical structure of (±)-DMBO (5). Chemical 
characterization of (±)-DMBO by 1H NMR and 13C NMR analysis.
Figure 5: ESI-MS/MS spectra in positive ion mode of capsiate, 
dihydrocapsiate and (±)-DMBO. The individual standard solutions 
in 60% methanol of 10 µmol L-1 capsiate (A) and dihydrocapsiate (B), 
and 20 µmol L-1 (±)-DMBO (C) were acquired by direct injection on the 
QTOF mass analyser. 
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shared by capsinoid standards. MS/MS spectra obtained 
for (±)-DMBO, capsiate, and dihydrocapsiate matched well 
with the typical fragmentation pattern for capsinoids [34] 
and capsaicinoids [35].
Ion chromatograms were extracted for the exact 
m/z values corresponding to the [M+Na]+ species of 
capsiate, (±)-DMBO, and dihydrocapsiate (Figure 6). The 
peaks of the capsiate, (±)-DMBO, and dihydrocapsiate 
standards showed their elution times at 31.0, 34.0, and 
35.3 min, respectively. Since the chromatogram traces 
corresponding to m/z 331 were extracted for (±)-DMBO 
and dihydrocapsiate, the resolution (Rs) of these two 
compounds was calculated in order to confirm the correct 
separation of both compounds. The Rs of dihydrocapsiate 
and (±)-DMBO (defined as 2 times the separation between 
peaks divided by the sum of the peak base widths) was 1.2, 
a value that can be considered as adequate. 
The potentiality of using (±)-DMBO as IS in capsinoid 
determination by ESI-mass spectrometry was supported 
by the following facts i) it is a capsinoid analogue not 
occurring naturally in Capsicum species, ii) the ionization 
behaviour of (±)-DMBO in ESI mass is similar to that of 
capsiate and dihydrocapsiate, and iii) its retention time is 
similar to that of capsiate and dihydrocapsiate, (±)-DMBO 
eluting between the two analytes but being able to be 
separated from dihydrocapsiate.
Conclusion4  
In this study, a (±)-DMBO synthesis procedure has been 
described. The synthesis procedure developed is simple, 
economical, and achievable in any basic chemistry 
laboratory, and it also allows the obtaining of yields 
greater than 95%. 
(±)-DMBO could be a potential IS for capsinoid 
determination because: (i) it is not present in pepper fruits; 
(ii) it is stable under analysis conditions; (iii) it elutes 
between capsiate and dihydrocapsiate; (iv) its chemical 
structure is closely related to that of capsinoids; (v) and its 
ionization behaviour and fragmentation pattern is shared 
by capsiate and dihydrocapsiate. 
As far as we know, there is not any other IS 
available for capsinoid determination by HPLC-ESI-MS/
MS(QTOF) analysis. Synthetic analogues have already 
been successfully used as IS for another compound 
determination by ESI-MS techniques [36-37]. We have 
described for first time a simple synthesis approach of 
a capsinoid analogue suitable for IS. The development 
of a new IS will allow an accurate quantification of 
capsinoid by HPLC-ESI-MS, a useful tool for screening 
and selecting of cultivars containing capsinoids in pepper 
breeding programs and for gaining understanding of the 
metabolism of capsinoids.
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